MLTX Stock Analysis: Buy, Sell, or Hold?
MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares
$12.67
2.02 (18.97%)
▲
5d:
+23.49%
30d:
-1.78%
90d:
-33.39%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When MLTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MLTX shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
✅ BUY SIGNAL: MLTX shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
In-depth Analysis How we analyze
Valuation Analysis: MLTX is currently trading at $12.67, which is considered extended relative to its 30-day fair value range of $10.43 to $12.44.
Technical Outlook: Technically, MLTX is in a strong downtrend. The price is approaching resistance at $11.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 19.0% recently.
Market Sentiment: MLTX scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.54 (+168.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MLTX is in a strong downtrend. The price is approaching resistance at $11.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 19.0% recently.
Market Sentiment: MLTX scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.54 (+168.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.43 -
$12.44
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (91/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+19.0%)
- BULLISH: Trading 168.0% below Wall St target ($28.54)
- BULLISH: Bottoming setup score 91/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$10.43 -
$12.44
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.46
Resistance Level
$11.09
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.20
Wall Street Target
$28.54
(+168.0%)
Share & Embed Analysis
Last updated: October 22, 2026 12:06 PM ET
Data refreshes hourly during market hours. Next update: 1:06 PM
Data refreshes hourly during market hours. Next update: 1:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 68 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 71 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 60 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 60 BUY |
Advanced MLTX Option Strategies
Professional options setups generated by AI based on today's MLTX price and gamma walls.